JPRN-UMIN000004183
Completed
未知
A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease-Its effect on biliary bigly metabolism- - A study on efficacy of Ezetimibe in patients with Dyslipidemia associated with Digestive disease
Hiroshima University hospital Department of General Medicine0 sites60 target enrollmentSeptember 10, 2010
Conditionshypercholesterolemia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hypercholesterolemia
- Sponsor
- Hiroshima University hospital Department of General Medicine
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients who are treated with insulin 2\)HbA1\>\=8% 3\)History ofhypersensitivity to Ezetimibe 4\)Serious hepatic disfunctions 5\)Patient whom biliary tract comletely blockaded 6\)Serious kidney disfunctions 7\)AMI,angina and stroke within 3 months before intervention 8\)Secondary hypercholesterolemia or medical hypercholesterolemia 9\)Pregnant or lactating women and women who may be pregnant 10\)Familial hypercholesterolemia 11\)Bronchial Asthma or an allergic disease 12\)Judged by investigator not to be appropriate for inclusion in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Therapeutic fficacy of ezetimibe in patients with nonalcoholic steatohepatitis (NASH): a pilot study.onalcoholic steatohepatitis (NASH)JPRN-UMIN000001258Division of Gastroenterology, Yokohama City University Hospital10
Completed
Not Applicable
Efficacy of Ezetimibe for the patients with Non-alcoholic fatty liver disease (NAFLD)JPRN-UMIN000001071Osaka City University Graduate School of Medicine60
Recruiting
Not Applicable
Effects of ezetimibe combination therapy for patients with atherosclerotic cardiovascular disease; randomized comparison of LDL-cholesterol targeting <70 versus <55mg/dL; Ez-PAVE trialDiseases of the circulatory systemKCT0005547Yonsei University Health System, Severance Hospital3,048
Completed
Not Applicable
Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.Dyslipidemia complicated insulin resistanceJPRN-UMIN000005775The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital47
Completed
Not Applicable
Combination therapy with Ezetimibe and Gemfibrozile on post-prandial hypertriglyceridemiaDiabetes.Non-insulin-dependent diabetes mellitusIRCT201105311179N5Zanjan Metabolic Research Center, Zanjan University of medical science90